Navigation Links
Biotechnology and Environmental Protection at this Year's ACHEMA
Date:6/17/2012

BERLIN, June 17, 2012 /PRNewswire/ --

Germany Trade & Invest attends the most important exhibition in the chemical industry

From having the image of an environmental enemy to becoming an energy efficient innovator: the German chemical industry has made a remarkably positive transformation in the past few years. The new energy era has created even greater pressure on the industry to become more resource efficient, especially since nuclear energy is being phased out. Experts from Germany Trade & Invest will highlight opportunities at ACHEMA on June 18 in Frankfurt.

"German fuel- and fertilizer companies have either relocated or had to strategically reposition themselves. New materials, renewable raw materials, clean-tech, energy and mobility are cutting-edge fields that are necessary for the sector to explore," stated Evelyn Moeck, Director of Chemicals & Healthcare at Germany Trade & Invest.

The German chemical industry, ranked number one in Europe and number four globally, has constantly had to reinvent itself to adapt. The rapidly changing market and increasing competition from Asia are forcing local companies to improve productivity and step up innovation. The industry invests 5.5 percent of total sales in the development of new products. Only the automobile industry has invested more. One in ten workers in the chemical field is in the research and development department. As a result, Germany has the third most registered chemical patents, behind Japan and the United States. The intensive R&D is also reflected in a 40 percent cut in energy usage between 1996 and 2006.

"Energy efficiency is more significant than ever, much like other issues such as energy storage. Specialization and "innovative alliances" are gaining influence in the sector. Companies will have to start developing new products together, which will create greater cooperation between large companies and small and medium enterprises," continued Moeck.

Germany Trade & Invest is the foreign trade and inward investment promotion agency of the Federal Republic of Germany. The organization advises foreign companies looking to expand their business activities in the German market. It provides information on foreign trade to German companies that seek to enter foreign markets.

Germany Trade & Invest
Andreas Bilfinger
Email: andreas.bilfinger@gtai.com
T: +49(0)30 200099-173
F: +49(0)30 200099-511
http://www.gtai.com
http://twitter.com/gtai_com
http://youtube.com/gtai
http://www.linkedin.com/company/germany-trade-&-invest


'/>"/>
SOURCE Germany Trade and Invest
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Choose New Jersey, Inc. to Tout New Jerseys Life Sciences Hub At Worlds Largest Biotechnology Event
2. Global Biotechnology Instrumentation Industry
3. New Study: Health Professionals Support Biotechnologys Use In Food Products And Sustainable Farming
4. Lixte Biotechnology Receives US Patent for Its Proprietary Histone Deacetylase Inhibitor
5. Apexigen and Shanghai Duyiwei Biotechnology Co. Ltd Sign a License and Collaboration Agreement to Develop and Commercialize APX004
6. Global Biotechnology Industry
7. JumpStart Invests $250,000 in Milo Biotechnology
8. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
9. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
10. Animal Biotechnology - Technologies, Markets and Companies
11. Puma Biotechnology Announces Completion of Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... MA (PRWEB) , ... January 17, 2017 , ... ... the completely re-engineered Drug Safety Technology Consortium™ (SafeTEC™), $3 million in investment towards ... validating these new tools and assays, and their applicability in drug safety assessment, ...
(Date:1/16/2017)... ... January 16, 2017 , ... Appellate Court ... decision on the appeal filed by India-based Dishman Pharmaceutical & Chemical Ltd. company ... DPCL and one of its Dishman Group’s 100% wholly owned New Jersey-based subsidiary ...
(Date:1/14/2017)...  The Alliance for Safe Biologic Medicines (ASBM) today ... final guidance on biologic naming: We ... the importance of distinct naming for all biologics, including ... biosimilars will bring to patients, including new treatment options ... of the Guidance dealing with suffix design remains at ...
(Date:1/13/2017)... ... January 13, 2017 , ... FireflySci, in response to several ... new solutions for measurements where traditional cuvette applications are not convenient. For instance, ... oddly-shaped sample that would not fit into a typical cuvette inside a spectrophotometer. ...
Breaking Biology Technology:
(Date:12/19/2016)... y TORONTO , 19 de diciembre de 2016 ... Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado ... tipos de tumor en 2017, con múltiples sitios previstos a lo ... ... objetivo en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica ...
(Date:12/15/2016)... 15, 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... company, announced today that on December 13, 2016, it ... The Nasdaq Stock Market LLC which acknowledged that, as ... WaferGen,s common stock had been at $1.00 or greater ... compliance with Listing Rule 5550(a)(2) of the Nasdaq Stock ...
(Date:12/12/2016)... Dec. 12, 2016  Researchers at Trinity College, ... graphene by combining the material with Silly Putty. The ... pressure detector able to sense pulse, blood pressure, ... spider.  The research team,s findings ... read here:  http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):